EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $124,019 | -30.7% | 17,106 | +16.9% | 0.01% | -35.7% |
| Q3 2022 | $179,000 | +306.8% | 14,636 | +522.0% | 0.01% | +250.0% |
| Q1 2022 | $44,000 | -86.7% | 2,353 | -70.3% | 0.00% | -87.5% |
| Q1 2021 | $332,000 | +2666.7% | 7,928 | +4304.4% | 0.03% | +3100.0% |
| Q4 2020 | $12,000 | +200.0% | 180 | +9.8% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -96.3% | 164 | -95.6% | 0.00% | -90.9% |
| Q4 2019 | $109,000 | +626.7% | 3,700 | +428.6% | 0.01% | +1000.0% |
| Q3 2019 | $15,000 | -94.3% | 700 | -90.5% | 0.00% | -94.4% |
| Q2 2018 | $262,000 | +303.1% | 7,335 | +270.6% | 0.02% | +200.0% |
| Q1 2018 | $65,000 | -44.9% | 1,979 | -60.0% | 0.01% | -45.5% |
| Q3 2017 | $118,000 | +84.4% | 4,947 | +27.8% | 0.01% | +83.3% |
| Q2 2017 | $64,000 | -30.4% | 3,870 | -6.7% | 0.01% | -40.0% |
| Q1 2017 | $92,000 | – | 4,146 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |